MYAM
HZNP

Meiji Yasuda Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Meiji Yasuda Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,346
Closed -$1.66M – 631
2023
Q3 		$1.66M Buy
14,346
+9,150
+176% +$983K 0.08% 256
2023
Q2 		$534K Sell
5,196
-920
-15% -$97.1K 0.03% 390
2023
Q1 		$668K Sell
6,116
-14,224
-70% -$1.57M 0.03% 346
2022
Q4 		$2.31K Sell
20,340
-190
-0.9% -$15.8K 0.11% 221
2022
Q3 		$1.27M Sell
20,530
-330
-2% -$23.1K 0.07% 277
2022
Q2 		$1.66M Buy
20,860
+9,290
+80% +$880K 0.1% 243
2022
Q1 		$1.22M Sell
11,570
-360
-3% -$35.1K 0.07% 294
2021
Q4 		$1.29M Sell
11,930
-2,722
-19% -$297K 0.08% 234
2021
Q3 		$1.6M Buy
14,652
+122
+0.8% +$12.7K 0.11% 184
2021
Q2 		$1.36M Buy
14,530
+11,990
+472% +$1.1M 0.06% 213
2021
Q1 		$234K Buy
+2,540
New +$214K 0.02% 477

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Meiji Yasuda Asset Management's HZNP Position: Q4 2023 in Review

Meiji Yasuda Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 14,346 shares — an estimated $1.66M sold.

Meiji Yasuda Asset Management first reported a position in HZNP in Q1 2021 and held it in 11 quarters. The position peaked at $1.66M in Q2 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Meiji Yasuda Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Meiji Yasuda Asset Management sold 14,346 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.66M.
  • Meiji Yasuda Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 11 quarters.
  • Meiji Yasuda Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.66M in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.